Seattle Children’s hospital faces lawsuit over mold issues

Lawsuit claims that the teen contracted meningitis in March 2018 from the Aspergillus mold


Seattle Children’s hospital is being sued by the parents of a teenage boy who allege that the hospital’s mold problem caused an infection that left their son disabled, according to an article on the Seattle Times website.

Seattle Children’s is closing all operating rooms on its Seattle campus for at least five days to address a recurring mold problem that, since last year, has killed one patient and sickened at least six others.

The lawsuit claims that the teen contracted meningitis in March 2018 from the Aspergillus mold that has repeatedly been found in the hospital’s operating rooms.

At least four patients have been sickened by the fungus this year, and at least three were infected in 2018, one of whom died.

Read the article.



November 20, 2019


Topic Area: Infection Control


Recent Posts

Healthcare Is the New Retail

How site selection strategies are shaping the future of medical real estate.


Bridgeway Behavioral Health Services Launches Campaign to Renovate Health Center

The $2 million capital campaign aims to renovate and expand the outpatient behavioral health center in Elizabeth, New Jersey.


Ground Broken for New North Dakota State Hospital

The 300,000-square-foot facility in Jamestown will provide 140 beds in a modern, trauma-informed care environment.


AI Usage for Healthcare Facilities

People in all industries are finding more use cases for artificial intelligence.


Ground Broken on Pelican Valley Senior Living Modernization Project

It is expected to reach completion in early-mid 2027.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.